Allergy and Infectious Diseases Research in Virginia
Allergy and Infectious Diseases Research (93.855) awarded $233 million to recipients in Virginia in 233 grants from fiscal 2021 to 2025, 1.1% of the program's national total. Rector & Visitors of the University of Virginia received the most, $131 million.
- Awarded in Virginia$233 million
- Awards233
- Share of the program1.1%
- Rank among states22nd of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 109 | $40.7 million |
| FY 2022 | 105 | $50.2 million |
| FY 2023 | 99 | $45.6 million |
| FY 2024 | 106 | $46.4 million |
| FY 2025 | 99 | $50.2 million |
Recipients in Virginia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rector & Visitors of the University of Virginia | Colleges and universities | 123 | $131 million |
| Virginia Polytechnic Institute & State University | Colleges and universities | 55 | $38.4 million |
| Virginia Commonwealth University | Colleges and universities | 26 | $27.8 million |
| George Mason University | Colleges and universities | 5 | $15.9 million |
| Old Dominion University | Colleges and universities | 7 | $8.3 million |
| American Type Culture Collection | Nonprofits | 1 | $3.9 million |
| Indoor Biotechnologies, Inc. | Small businesses | 1 | $3.0 million |
| Biotherapeutics, Inc. | Small businesses | 6 | $2.7 million |
| Qentoros LLC | Small businesses | 1 | $600,000 |
| Glycomantra Inc | Small businesses | 1 | $596,637 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Virginia?
$233 million from fiscal 2021 to 2025, across 233 awards. Virginia ranks 22nd of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Virginia?
The largest recipient is Rector & Visitors of the University of Virginia, with $131 million in 123 awards. Next are Virginia Polytechnic Institute & State University and Virginia Commonwealth University.
Can organizations in Virginia apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Virginia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Emergency Food and Shelter National Board Program